离体荧光共聚焦显微镜评估输尿管镜活检标本 adequacy 在上尿路尿路上皮癌中的可行性
这项前瞻性单中心可行性研究纳入2例疑似上尿路尿路上皮癌患者,对4份输尿管镜活检标本行离体荧光共聚焦显微镜(FCM)实时评估标本 adequacy。FCM 可在约5分钟内完成制片与图像采集,盲法判读识别出3份含尿路上皮组织的 adequate 标本,与 H&E 结果一致;结论认为 FCM 可行且不影响标准病理评估,但需更大样本验证。
要点
- 离体 FCM 可在约5分钟/标本内完成新鲜输尿管镜活检标本的实时成像。
- 盲法 FCM 判读可识别含尿路上皮组织的标本,与 H&E adequacy 评估一致。
- FCM 评估不影响后续标准组织病理学检查,初步支持扩大样本验证。
核心结论
- 离体 FCM 对新鲜输尿管镜活检标本行即时成像可行,可识别含尿路上皮碎片作为标本 adequacy 标志,同时保留组织供标准病理评估。
研究设计与样本
- 前瞻性单中心可行性研究,纳入2例疑似上尿路尿路上皮癌患者,分析4份输尿管镜活检标本,行离体 FCM 后与常规 H&E 病理对照。
主要发现
- FCM 在所有标本上成功完成,无流程中断,总制片与图像采集约5分钟/标本。
- 盲法 FCM 判读在4份标本中识别出3份含尿路上皮组织并判为 adequate,1份以血凝块为主、仅含极少非诊断性细胞材料判为非代表。
- FCM 的 adequacy 评估与对应 H&E 切片一致;最终病理示1例非浸润性乳头状尿路上皮癌高级别、另1例低级别,非代表标本仅见灶性非典型乳头状尿路上皮增生混杂于血凝块中。
关键数值与推荐
- 标本 adequacy 的预设标准为可识别尿路上皮组织。
- FCM 扫描时间在50-60秒内完成,总制备与图像采集约5分钟/标本。
临床怎么用
- FCM 可作为术中或实时评估输尿管镜活检标本 adequacy 的辅助手段,帮助判断是否含可诊断的尿路上皮组织,且不影响后续标准病理。
局限性
- 研究为单中心可行性研究,样本量仅2例患者、4份标本,结果需更大队列验证可重复性。
- 尚未明确 FCM 与最终病理分级和分期的相关性,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the feasibility of ex vivo fluorescence confocal microscopy (FCM) for real-time assessment of ureteroscopic biopsy specimen adequacy in patients with suspected upper tract urothelial carcinoma (UTUC). PATIENTS AND METHODS: In this prospective, single-centre feasibility study, four ureteroscopic biopsy specimens obtained from two patients undergoing evaluation for suspected UTUC were analysed using ex vivo FCM. Specimens were briefly stained with acridine orange, scanned within 50-60 s, and images were stored for deferred review. A board-certified genitourinary pathologist reviewed the FCM images in a blinded fashion and classified specimens as adequate or non-representative based on a pre-defined criterion of identifiable urothelial tissue. All specimens subsequently underwent routine haematoxylin and eosin (H&E) histopathological analysis for confirmation. RESULTS: Ex vivo FCM was successfully performed on all specimens without workflow interruption, with total preparation and image acquisition completed within approximately 5 min/specimen. Blinded FCM review identified urothelial tissue in three of four biopsy specimens, which were classified as adequate, while one specimen was composed predominantly of blood clot with only minimal, non-diagnostic cellular material and was therefore classified as non-representative. FCM-based adequacy assessments were concordant with corresponding H&E sections. Final histopathology demonstrated non-invasive papillary UC, high grade in one patient and low grade in the other; the non-representative specimen showed only focal atypical papillary urothelial proliferation admixed within the blood clot. CONCLUSION: Ex vivo FCM was feasible for immediate imaging of freshly obtained ureteroscopic biopsy specimens and allowed identification of urothelial-containing fragments as a marker of specimen adequacy while preserving tissue for standard histopathological evaluation. These preliminary findings support further investigation in larger cohorts to evaluate reproducibility and to clarify the potential role of this approach for intraoperative or real-time assessment of biopsy adequacy in UTUC, including correlation with final histopathological grade and stage.
引用
- Daher K, Soputro NA, El Hussein M, et al. Ex vivo fluorescence confocal microscopy for assessment of ureteroscopic biopsy adequacy in upper tract urothelial carcinoma. BJU Int. 2026. PMID: 41991180. doi:10.1111/bju.70290
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。